Are you a print subscriber? Activate your account. By Ewan Larkin - 7 hours 53 min ago By Bradley Johnson - 8 hours 29 min ago By Tim Nudd - 9 hours 26 min ago By E.J. Schultz - 14 hours 16 min ago By ...
SOUTH SAN FRANCISCO, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results